My virtual escape from patient life: a feasibility study on the experiences and benefits of individualized virtual reality for inpatients in palliative cancer care.


Journal

BMC palliative care
ISSN: 1472-684X
Titre abrégé: BMC Palliat Care
Pays: England
ID NLM: 101088685

Informations de publication

Date de publication:
23 Oct 2024
Historique:
received: 11 06 2024
accepted: 14 10 2024
medline: 24 10 2024
pubmed: 24 10 2024
entrez: 24 10 2024
Statut: epublish

Résumé

Cancer patients benefit from Virtual Reality (VR) in burdensome situations, but evidence is scarce for palliative situations. Based on earlier work in palliative care, individualized VR interventions like seeing the patient's home may address a patient's wish to be at home and thus have a greater effect compared to standard VR content. Yet, some patients and relatives may be concerned about their privacy. Also, patient stakeholders raised concerns about triggering depressed mood or homesickness. To test the feasibility and safety of individualized vs. standard 360°video VR interventions in palliative cancer inpatients. Prospective observational study with patient-reported outcome measurement using validated instruments of well-being (MDBF), symptoms and psychosocial burden (IPOS), cybersickness (SSQ), presence experience (SPES), subjective benefit (2 items), content analysis of interviews, and field notes. Individualized VR content was recorded with action camcorder-technology to protect the patients' privacy. Seventeen patients participated, median age 65 years (range 20-82), 9 women (53%), 8 single or widowed (47%), 4 childless (23.5%), 4 academics (23.5%), with a median length of stay of 9 days (1-75) in the hematology (10), palliative care (3), or radiotherapy (2) unit of a German university hospital. Eight patients (53.3%) chose their own home environments or family for individualized VR-content. All participants enjoyed the intervention. Compared to standard VR content the individualized VR tended to have a stronger effect on well-being and emotional touch. It was not inferior in terms of psychosocial burden and cybersickness. No subjective and relevant side effects occurred. The patients well tolerated the assessments. However, most patients demanded a lighter headset and a desire for more interactivity. Individualization of VR content shows potential for enhancement of immersion, which improves the VR experience and does not harm in terms of depressed mood or worsening of symptoms. The patients' and family desire for privacy is feasible with the support of family members who recorded the individualized videos, which is easily manageable today. We suggest a pragmatic randomized clinical trial to compare the effects of individualized vs. standard VR-content. Registered at German Clinical Trials Register (Deutsches Register Klinischer Studien; DRKS); registration number: DRKS00032172; registration date: 11/07/2023.

Sections du résumé

BACKGROUND BACKGROUND
Cancer patients benefit from Virtual Reality (VR) in burdensome situations, but evidence is scarce for palliative situations. Based on earlier work in palliative care, individualized VR interventions like seeing the patient's home may address a patient's wish to be at home and thus have a greater effect compared to standard VR content. Yet, some patients and relatives may be concerned about their privacy. Also, patient stakeholders raised concerns about triggering depressed mood or homesickness.
AIM OBJECTIVE
To test the feasibility and safety of individualized vs. standard 360°video VR interventions in palliative cancer inpatients.
METHODS METHODS
Prospective observational study with patient-reported outcome measurement using validated instruments of well-being (MDBF), symptoms and psychosocial burden (IPOS), cybersickness (SSQ), presence experience (SPES), subjective benefit (2 items), content analysis of interviews, and field notes. Individualized VR content was recorded with action camcorder-technology to protect the patients' privacy.
RESULTS RESULTS
Seventeen patients participated, median age 65 years (range 20-82), 9 women (53%), 8 single or widowed (47%), 4 childless (23.5%), 4 academics (23.5%), with a median length of stay of 9 days (1-75) in the hematology (10), palliative care (3), or radiotherapy (2) unit of a German university hospital. Eight patients (53.3%) chose their own home environments or family for individualized VR-content. All participants enjoyed the intervention. Compared to standard VR content the individualized VR tended to have a stronger effect on well-being and emotional touch. It was not inferior in terms of psychosocial burden and cybersickness. No subjective and relevant side effects occurred. The patients well tolerated the assessments. However, most patients demanded a lighter headset and a desire for more interactivity.
CONCLUSIONS CONCLUSIONS
Individualization of VR content shows potential for enhancement of immersion, which improves the VR experience and does not harm in terms of depressed mood or worsening of symptoms. The patients' and family desire for privacy is feasible with the support of family members who recorded the individualized videos, which is easily manageable today. We suggest a pragmatic randomized clinical trial to compare the effects of individualized vs. standard VR-content.
TRIAL REGISTRATION BACKGROUND
Registered at German Clinical Trials Register (Deutsches Register Klinischer Studien; DRKS); registration number: DRKS00032172; registration date: 11/07/2023.

Identifiants

pubmed: 39443900
doi: 10.1186/s12904-024-01577-2
pii: 10.1186/s12904-024-01577-2
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

247

Informations de copyright

© 2024. The Author(s).

Références

Weiss PL, Kizony R, Feintuch U, Katz N. Virtual reality in neurorehabilitation. In: Selzer M, Clarke S, Cohen L, Duncan P, Gage F, editors. Textbook of Neural Repair and Rehabilitation 2: Medical Neurorehabilitation. Cambridge: Cambridge University Press. 2006;182–97.
Wu Y, Wang N, Zhang H, Sun X, Wang Y, Zhang Y. Effectiveness of Virtual Reality in Symptom Management of Cancer Patients: A Systematic Review and Meta-Analysis. J Pain Symptom Manage. 2023;65(5):e467-482.
doi: 10.1016/j.jpainsymman.2023.01.023 pubmed: 36758907
Mo J, Vickerstaff V, Minton O, Tavabie S, Taubert M, Stone P, White N. How effective is virtual reality technology in palliative care? A systematic review and meta-analysis. Palliat Med. 2022;36(7):1047–58.
doi: 10.1177/02692163221099584 pubmed: 35635018 pmcid: 9248003
Moloney M, Doody O, O’Reilly M, Lucey M, Callinan J, Exton C, Colreavy S, O’Mahony F, Meskell P, Coffey A. Virtual reality use and patient outcomes in palliative care: A scoping review. Digital Health. 2023;9:1–16
Martin JL, Saredakis D, Hutchinson AD, Crawford GB, Loetscher T. Virtual Reality in Palliative Care: A Systematic Review. Healthcare. 2022;10(7):1222.
doi: 10.3390/healthcare10071222 pubmed: 35885749 pmcid: 9319274
Niki K, Okamoto Y, Maeda I, Mori I, Ishii R, Matsuda Y, Takagi T, Uejima E. A Novel Palliative Care Approach Using Virtual Reality for Improving Various Symptoms of Terminal Cancer Patients: A Preliminary Prospective. Multicenter Study J Palliat Med. 2019;22(6):702–7.
doi: 10.1089/jpm.2018.0527 pubmed: 30676847
Nwosu AC, Mills M, Roughneen S, Stanley S, Chapman L, Mason SR. Virtual reality in specialist palliative care: a feasibility study to enable clinical practice adoption. BMJ Support Palliat Care. 2021;14(1):47–51.
doi: 10.1136/bmjspcare-2020-002327 pmcid: 10894832
Pittara M, Matsangidou M, Stylianides K, Petkov N, Pattichis CS. Virtual Reality for Pain Management in Cancer: A Comprehensive Review. IEEE Access. 2020;8:225475–89.
doi: 10.1109/ACCESS.2020.3044233
Pizzoli SFM, Mazzocco K, Triberti S, Monzani D, Alcañiz Raya ML, Pravettoni G. User-Centered Virtual Reality for Promoting Relaxation: An Innovative Approach. Front Psychol. 2019. https://doi.org/10.3389/fpsyg.2019.00479 .
Gerlach C, Greinacher A, Alt-Epping B, Wrzus C. My virtual home: needs of patients in palliative cancer care and content effects of individualized virtual reality – a mixed methods study protocol. BMC Palliat Care. 2023;22:167.
Gerlach C, Greinacher A, Heiligtag C, Lantelme J, Sefovic A, Alt-Epping B, Wrzus C. My Virtual Home: Needs and Concerns of Palliative Cancer Patients Regarding Individualized Virtual Reality. Palliative Med. 2024;38 Suppl 1:171.
Greinacher A, Alt-Epping B, Gerlach C and Wrzus C. Expected benefits and concerns regarding virtual reality in caring for terminally ill cancerpatients – a qualitative interview study. BMC Palliat Care. 2024. https://doi.org/10.1186/s12904-024-01557-6 .
Desselle MR, Holland LR, McKittrick A, Kennedy G, Yates P, Brown J. “A Wanderer’s Tale”: The development of a virtual reality application for pain and quality of life in Australian burns and oncology patients. Palliat Support Care. 2023;21(3):454–60.
doi: 10.1017/S1478951522000530 pubmed: 35678170
Mukai T, Tsukiyama Y, Yamada S, Nishikawa A, Hayami S, Noguchi R, Yoshida J, Kashiwada M, Ohta S, Shimokawa T, Yamaue H. Virtual Reality Images of the Home Are Useful for Patients With Hospital-Based Palliative Care: Prospective Observational Study With Analysis by Text Mining. Palliat Med Rep. 2023;4(1):214–9.
doi: 10.1089/pmr.2023.0017 pubmed: 37645585 pmcid: 10460958
Seiler A, Schettle M, Amann M, Gaertner S, Wicki S, Christ SM, Theile G, Feuz M, Hertler C, Blum D. Virtual Reality Therapy in Palliative Care: A Case Series. J Palliat Care. 2022. https://doi.org/10.1177/08258597221086767 .
Woo OKL. Integrating knowledge, skills, and attitudes: professional training required for virtual reality therapists in palliative care. Front Med Technol. 2023;5:1268662.
doi: 10.3389/fmedt.2023.1268662 pubmed: 37849786 pmcid: 10577415
Steyer R, Schwenkmezger P, Notz P, Eid M. Testtheoretische Analysen des Mehrdimensionalen Befindlichkeitsfragebogen (MDBF) [Theoretical analysis of a multidimensional mood questionnaire (MDBF)]. Diagnostica. 1994;40(4):320–8.
Murtagh FEM, Ramsenthaler C, Firth A, Groeneveld EI, Lovell N, Simon ST, Denzel J, Guo P, Bernhardt F, Schildmann E, van Oorschot B, Hodiamont F, Streitwieser S, Higginson IJ, Bausewein C. A brief, patient- and proxy-reported outcome measure in advanced illness: Validity, reliability and responsiveness of the Integrated Palliative care Outcome Scale (IPOS). Palliat Med. 2019;33(8):1045–57.
doi: 10.1177/0269216319854264 pubmed: 31185804 pmcid: 6691591
Kennedy RS, Lane NE, Berbaum KS, Lilienthal MG. Simulator Sickness Questionnaire: An Enhanced Method for Quantifying Simulator Sickness. Int J Aviat Psychol. 1993;3(3):203–20.
doi: 10.1207/s15327108ijap0303_3
Hartmann T, Wirth W, Schramm H, Klimmt C, Vorderer P, Gysbers A, Böcking S, Ravaja N, Laarni J, Saari T, Gouveia F, Maria SA. The Spatial Presence Experience Scale (SPES): A Short Self-Report Measure for Diverse Media Settings. J Media Psychol. 2016;28(1):1–15.
doi: 10.1027/1864-1105/a000137
Rädiker S, Kuckartz U. Analyse qualitativer Daten mit MAXQDA. 1st ed. Wiesbaden: Springer VS; 2019.
Ritchie J, Ormston R, McNaughton Nicholls C, Lewis J. Qualitative Research Practice : A Guide for Social Science Students and Researchers. London: SAGE Publications Ltd; 2013. Available from: http://digital.casalini.it/9781446296202
Guenther M, Görlich D, Bernhardt F, Pogatzki-Zahn E, Dasch B, Krueger J, Lenz P. Virtual reality reduces pain in palliative care–A feasibility trial. BMC Palliat Care. 2022;21(1):169.
doi: 10.1186/s12904-022-01058-4 pubmed: 36195865 pmcid: 9533542
Moon NO, Henstridge-Blows JR, Sprecher EA, Thomas E, Byfield A, McGrane J. ‘Godrevy Project’: virtual reality for symptom control and well-being in oncology and palliative care – a non-randomised pre-post interventional trial. BMJ Oncol. 2023;2(1):e000160.
doi: 10.1136/bmjonc-2023-000160
Chaze F, Hayden L, Azevedo A, Kamath A, Bucko D, Kashlan Y, Dube M, De Paula J, Jackson A, Reyna C, Warren-Norton K, Dupuis K, Tsotsos L. Virtual reality and well-being in older adults: Results from a pilot implementation of virtual reality in long-term care. J Rehabil Assist Technol Eng. 2022;9:1–12.
Matsangidou M, Frangoudes F, Schiza E, Neokleous KC, Papayianni E, Xenari K, Avraamides M, Pattichis CS. Participatory design and evaluation of virtual reality physical rehabilitation for people living with dementia. Virtual Reality. 2022;27(1):421–38.
doi: 10.1007/s10055-022-00639-1
Pinto-Coelho L, Laska-Leśniewicz A, Pereira ET, Sztobryn-Giercuszkiewicz J. Inclusion and adaptation beyond disability: Using virtual reality to foster empathy. Med Pr. 2023;74(3):171–85.
pubmed: 37695931
Colosimo K, Nissim R, Pos AE, Hales S, Zimmermann C, Rodin G. “Double awareness” in psychotherapy for patients living with advanced cancer. J Psychother Integr. 2018;28(2):125–40.
doi: 10.1037/int0000078
Rodin G, Zimmermann C. Psychoanalytic Reflections on Mortality: A Reconsideration. J Am Acad Psychoanal Dyn Psychiatry. 2008;36(1):181–96.
doi: 10.1521/jaap.2008.36.1.181 pubmed: 18399753
El-Jawahri A, Nelson AM, Gray TF, Lee SJ, LeBlanc TW. Palliative and End-of-Life Care for Patients With Hematologic Malignancies. J Clin Oncol. 2020;38(9):944–53.
doi: 10.1200/JCO.18.02386 pubmed: 32023164 pmcid: 8462532
Gerlach C, Alt-Epping B, Oechsle K. Specific challenges in end-of-life care for patients with hematological malignancies. Curr Opin Support Palliat Care. 2019;13(4):369–79.
doi: 10.1097/SPC.0000000000000470 pubmed: 31644451
Moore G, Campbell M, Copeland L, Craig P, Movsisyan A, Hoddinott P, Littlecott H, O’Cathain A, Pfadenhauer L, Rehfuess E, Segrott J, Hawe P, Kee F, Couturiaux D, Hallingberg B, Evans R. Adapting interventions to new contexts-the ADAPT guidance. BMJ. 2021;374:n1679.
doi: 10.1136/bmj.n1679 pubmed: 34344699 pmcid: 8329746
Navigate E. Supporting older people with cancer [Available from: https://eunavigate.com/ .
RE-AIM. Improving Public Health Relevance and Population Health Impact [Available from: https://re-aim.org .]

Auteurs

Christina Gerlach (C)

Department of Palliative Medicine, Heidelberg University Hospital, Im Neuenheimer Feld 305, 69120, Heidelberg, Germany. christina.gerlach@med.uni-heidelberg.de.

Laura Haas (L)

Department of Palliative Medicine, Heidelberg University Hospital, Im Neuenheimer Feld 305, 69120, Heidelberg, Germany.
Psychological Institute and Network Aging Research, Ruprecht Karls University of Heidelberg, Bergheimer Str. 20, 69115, Heidelberg, Germany.

Anja Greinacher (A)

Department of Palliative Medicine, Heidelberg University Hospital, Im Neuenheimer Feld 305, 69120, Heidelberg, Germany.
Clinical Psychology, Interaction- and Psychotherapy Research, Faculty of Social Sciences, University of Mannheim, L54, 68161, Mannheim, Germany.

Jonah Lantelme (J)

Department of Palliative Medicine, Heidelberg University Hospital, Im Neuenheimer Feld 305, 69120, Heidelberg, Germany.

Melanie Guenther (M)

Department of Palliative Medicine, Heidelberg University Hospital, Im Neuenheimer Feld 305, 69120, Heidelberg, Germany.

Julia Thiesbonenkamp-Maag (J)

Department of Palliative Medicine, Heidelberg University Hospital, Im Neuenheimer Feld 305, 69120, Heidelberg, Germany.

Bernd Alt-Epping (B)

Department of Palliative Medicine, Heidelberg University Hospital, Im Neuenheimer Feld 305, 69120, Heidelberg, Germany.

Cornelia Wrzus (C)

Psychological Institute and Network Aging Research, Ruprecht Karls University of Heidelberg, Bergheimer Str. 20, 69115, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH